Gazelle Parent, INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NASDAQ
Obsidian Therapeutics, Inc. announced the completion of its merger with Galera Therapeutics, Inc. and a $350 million private placement, bolstering its cash position to fund operations into late 2028.